Triple-Negative Breast Cancer Patients-Japanese Journal Of Clinical Oncology-Pharmacokinetic Profiles

Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study

ConclusionsThe safety, efficacy and pharmacokinetic profiles of neratinib are consistent with those reported for non-Japanese patients and warrant further investigation of neratinib in Japanese patients with solid tumors. (Source: Japanese Journal of Clinical Oncology) read more..

source:http://www.medworm.com

High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients

ConclusionsThe degree of miR-210 expression might be a clinically useful prognostic factor for decision-making regarding treatment in the adjuvant setting, especially in node-negative triple-negative breast cancer patients. (Source: Japanese Journal of Clinical Oncology) read more..

source:http://www.medworm.com

Cryoablation OK in Breast Ca Metastasis (CME/CE, with video)

SAN FRANCISCO (MedPage Today) -- Cryoablation of metastatic breast cancer tumors in the liver, kidney, lung, and soft tissues appears safe and may be a cost-effective means of managing the disease, researchers said here. (Source: MedPage Today OB/GYN) read more..

source:http://www.medworm.com